77398-05-1

Basic information

• Product Name: (2S,3S,4S)-2-methyl-3-(4-nitrobenzoyloxy)-4-trifluoracetamido-3,4-dihydro-2H-pyran
• Synonyms: (2S,3S,4S)-2-methyl-3-(4-nitrobenzoyloxy)-4-trifluoracetamido-3,4-dihydro-2H-pyran
• CAS NO: 77398-05-1
• Molecular Weight: 374.273
• Mol File: 77398-05-1.mol

Chemical Properties

• CAS DataBase Reference: (2S,3S,4S)-2-methyl-3-(4-nitrobenzoyloxy)-4-trifluoracetamido-3,4-dihydro-2H-pyran(CAS DataBase Reference)
• NIST Chemistry Reference: (2S,3S,4S)-2-methyl-3-(4-nitrobenzoyloxy)-4-trifluoracetamido-3,4-dihydro-2H-pyran(77398-05-1)
• EPA Substance Registry System: (2S,3S,4S)-2-methyl-3-(4-nitrobenzoyloxy)-4-trifluoracetamido-3,4-dihydro-2H-pyran(77398-05-1)

Safety Data

• Hazardous Substances Data: 77398-05-1(Hazardous Substances Data)

Upstream product

• 122-04-3 4-nitro-benzoyl chloride 
• 73864-37-6 3-amino-1,5-anhydro-2,3,6-tridesoxy-D-ribo-hex-1-enitol 
• 407-25-0 trifluoroacetic anhydride 
• 76739-66-7 3,4-di-O-acetyl-D-rhamnal 
• 51996-45-3 2,3,6-Trideoxy-3-trifluoroacetamido-L-lixo-hexopyranose 
• 76-05-1 trifluoroacetic acid 
• 73864-37-6 3-amino-1,5-anhydro-2,3,6-tridesoxy-D-arabino-hex-1-enitol 
• 76793-56-1 1,5-anhydro-2,3,6-tridesoxy-3-trifluoroacetamido-D-xylo-hex-1-enitol 
• 33647-98-2 methyl-2,3,6-tridesoxy-α-D-erythro-hex-2-enopyranoside 
• 33648-00-9 methyl-2,3,6-tridesoxy-α-D-threo-hex-2-enopyranoside 
• 33648-04-3 methyl-4-O-acetyl-2,3,6-tridesoxy-α-D-threo-hex-2-enopyranoside 
• 73864-37-6 3-amino-1,5-anhydro-2,3,6-tridesoxy-D-xylo-hex-1-enitol 
• 33648-02-1 methyl-4-O-acetyl-2,3,6-tridesoxy-α-D-erythro-hex-2-enopyranoside 
• 61819-51-0 methyl-4-O-benzoyl-2,3,6-tridesoxy-α-D-threo-hex-2-enopyranoside 

Downstream Products

• 70629-87-7 7-O-(2,3,6-tridesoxy-4-O-p-nitrobenzoyl-3-trifluoroacetamido-β-D-arabino-hexopyranosyl)daunomycinone 
• 70629-86-6 7-O-(2,3,6-tridesoxy-4-O-p-nitrobenzoyl-3-trifluoroacetamido-α-D-arabino-hexopyranosyl)daunomycinone 
• 76793-59-4 4-Nitro-benzoic acid (2R,3R,4S,6S)-6-((1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-naphthacen-1-yloxy)-2-methyl-4-(2,2,2-trifluoro-acetylamino)-tetrahydro-pyran-3-yl ester 
• 128164-28-3 C₃₈H₄₁F₉N₄O₁₃ 
• 128135-67-1 C₃₈H₄₁F₉N₄O₁₃ 
• 128135-64-8 C₃₃H₄₀F₉N₃O₁₁ 
• 128135-63-7 benzyl 4)-O-(2,3,6-trideoxy-3-trifluoroacetamido-α-L-lyxo-hexopyranosyl)-(1->4)-(2,3,6-trideoxy-3-trifluoroacetamido-α-L-lyxo-hexopyranoside)> 
• 128135-68-2 N-{(2S,3S,4S,6R)-6-Benzyloxy-3-[(2S,4S,5S,6S)-5-hydroxy-6-methyl-4-(2,2,2-trifluoro-acetylamino)-tetrahydro-pyran-2-yloxy]-2-methyl-tetrahydro-pyran-4-yl}-2,2,2-trifluoro-acetamide 
• 65222-75-5 (1S,2R,4S)-2-Ethyl-2,5,7-trihydroxy-4-((2R,4S,5S,6S)-5-hydroxy-6-methyl-4-methylamino-tetrahydro-pyran-2-yloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydro-naphthacene-1-carboxylic acid methyl ester 
• 65222-75-5 N-demethylaklavin 
• 78773-24-7 (1R,2R,4S)-2-Ethyl-2,5,7-trihydroxy-4-[(2R,4S,5S,6S)-6-methyl-4-[methyl-(2,2,2-trifluoro-acetyl)-amino]-5-(4-nitro-benzoyloxy)-tetrahydro-pyran-2-yloxy]-6,11-dioxo-1,2,3,4,6,11-hexahydro-naphthacene-1-carboxylic acid methyl ester 
• 78773-24-7 (1S,2S,4R)-2-Ethyl-2,5,7-trihydroxy-4-[(2R,4S,5S,6S)-6-methyl-4-[methyl-(2,2,2-trifluoro-acetyl)-amino]-5-(4-nitro-benzoyloxy)-tetrahydro-pyran-2-yloxy]-6,11-dioxo-1,2,3,4,6,11-hexahydro-naphthacene-1-carboxylic acid methyl ester 
• 60504-57-6 aklavin 
• 78773-23-6 4-Nitro-benzoic acid (2S,3S,4S)-2-methyl-4-[methyl-(2,2,2-trifluoro-acetyl)-amino]-3,4-dihydro-2H-pyran-3-yl ester 

Relevant articles and documents

Synthesis and cytotoxic activity of new 5H-indolo[2,3-b]quinoline O-aminoglycosides

Novel 5H-indolo[2,3-b]quinoline O-aminoglycosides were synthesized in order to check the hypothesis that the construction of hybrids composed of the active 5H-indolo[2,3-b]quinoline chromophore and daunosaminyl or acosaminyl moiety may result in the cytot

HEMISYNTHESE DE NOUVEAUX GLICOSIDES ANALOGUES DE LA DAUNORUBICINE

Seven daunorubicin analogs containing α-L-, α-D-, and β-D-glicosidic linkages, in which the natural occuring sugar (L-daunosamine) was replaced by diastereomeric 3-amino-2,3,6-trideoxyhexoses (3-epi-L-daunosamine, D-acosamine, D-daunosamine, D-ristosamine, and 3-epi-D-daunosamine), were prepared.In all cases, glycosidation with daunomycinone was performed in the presence of p-toluenesulfonic acid starting from 1-O-acetyl-2,3,6-trideoxy-4-O-p-nitrobenzoyl-3-trifluoro-acetamidohexopyranoses (prepared from the corresponding methyl 3-amino-2,3,6-trideoxyhexopyranosides) or from 1,5-anhydro-2,3,6-trideoxy-4-O-p-nitrobenzoyl-3-trifluoroacetamidohex-1-enitols (prepared from glycosals or pseudoglycals, the 3-amino group being introduced by substitution with sodium azide and subsequent reduction).Glycosidation was followed by removal of the protecting groups.